FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TEVERELIX
异名/同义词ANTARELIX
D-23234
D-ALANINAMIDE, N-ACETYL-3-(2-NAPHTHALENYL)-D-ALANYL-4-CHLORO-D-PHENYLALANYL-3-(3-PYRIDINYL)-D-ALANYL-L-SERYL-L-TYROSYL-N6-(AMINOCARBONYL)-D-LYSYL-L-LEUCYL-N6-(1-METHYLETHYL)-L-LYSYL-L-PROLYL-
EP-24332
N-ACETYL-3-(2-NAPHTHYL)-D-ALANYL-P-CHLORO-D-PHENYLALANYL-3-(3-PYRIDYL)-D-ALANYL-L-SERYL-L-TYROSYL-N(SUP 6)-CARBAMOYL-D-LYSYL-L-LEUCYL-N(SUP 6)-ISOPROPYL-L-LYSYL-L-PROLYL-D-ALANINAMIDE
TEVERELIX
TEVERELIX [INN]
CAS登记号151272-78-5
物质唯一标识(Unique Ingredient Identifier)D19V7048JK
分子式7079
国际化合物标识(International Chemical Identifier,InChI)
SMILESC74H100ClN15O14
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型NOENHWMKHNSHGX-IAOPALDYSA-N / C([C@H](NC([C@H]1N(CCC1)C([C@@H](NC([C@@H](NC([C@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@H](NC([C@H](NC(=O)C)Cc2cc3ccccc3cc2)=O)Cc4ccc(cc4)Cl)=O)Cc5cnccc5)=O)CO)=O)Cc6ccc(O)cc6)=O)CCCCNC(=O)N)=O)CC(C)C)=O)CCCCNC(C)C)=O)=O)C)(=O)N
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System